Endocrinology and nutrition
Service
Hospital Virgen del Camino
Pamplona, EspañaPublications in collaboration with researchers from Hospital Virgen del Camino (12)
2023
-
RECALSEEN 2021. Resources and quality in the Endocrinology and Nutrition units of the National Health System of Spain
Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 459-467
2022
-
How the COVID-19 pandemic has affected the training of Endocrinology and Nutrition Residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 219-226
-
Multidisciplinary consensus on nutritional and metabolic therapy in enhanced recovery after abdominal surgery programs: NutRICA Project
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 2, pp. 98-111
-
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases
The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320
2020
-
Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018
Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407
2019
-
Preoperative predictive model for acute kidney injury after elective cardiac surgery: A prospective multicenter cohort study
Minerva Anestesiologica, Vol. 85, Núm. 1, pp. 34-44
2018
-
Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017
Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496
2017
-
Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya
Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501
2016
-
Home Parenteral Nutrition in Spain, 2015. Home and Ambulatory Artificial Nutrition (NADYA) Group report
Nutricion Hospitalaria, Vol. 33, Núm. 6, pp. 1487-1490
2006
-
Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial
Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326
2003
-
Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage
Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481
2002
-
Características de la versión española del cuestionario de calidad de vida QLSM-H en sujetos adultos con deficiencia de hormona de crecimiento tratados con somatotropina. Estudio piloto
Endocrinologia y Nutricion, Vol. 49, Núm. 4, pp. 105-112